At Apollo, we’re committed to delivering the best service as well as the highest quality products. We guarantee you the quoted price, independent of the success of the initially planned synthetic route and regardless of whether more work is required to complete the synthesis successfully. What’s more, we explore alternative synthetic methods and purification procedures and can provide detailed options for scale-up synthesis in customer-tailored reports.
We are specialists in manufacturing small multifunctional and unusual substituted arenes and heterocycles. Currently we carry out reactions between -78°C and +250°C in conventional 50mL to 20L glass vessels under inert reactions conditions if required. As well as conventional batch synthesis, we operate a flow reactor system to assist with new reaction development and simple scale up of optimised reactions.
Download our Apollo Labs BrochureContact us
Our in-house manufacturing facilities enable us to undertake a wide variety of tasks, including custom synthesis, scale-up of existing routes, technology transfer to our commercial partners and development of novel compounds for our catalogue.
|Specialists in developing synthetic routes to new molecules
|Specialists in manufacturing small multifunctional and unusual substituted arenes and heterocycles
|In-house development of new compounds
|Global capabilities, powered by the entire Central Glass Group
|Sophisticated analytical techniques to ensure quality and consistency
We specialise in developing synthetic routes to new molecules, helping you find the solution you need. Thanks to our wide range of in-stock compounds, diverse sourcing network and expert dynamic synthesis team of PhD chemists, we can respond to custom requests quickly and flexibly. With a typical scale of 1-500g, we are also able to manufacture multiple kilos upon request and offer scale-up facilities and procedures that are adapted to each customer’s unique needs. We excel in quickly determining the best route and conditions to rapidly scale up production.
What we offer:
We’re constantly exploring and producing new molecules and developing our range of compounds in order to provide novel building blocks for research labs and kilo labs/pilot plants in the medicinal chemistry, pharmaceutical, agricultural, biotech and other life science industries. Over the last decade, more than 3,500 different compounds have been made in our UK and US labs. We do this by building on our own synthetic knowledge and experience accumulated over the last 20+ years, as well as analysing current literature and expanding on structures and scaffolds in demand from the chemical industry. Along with this, we utilise and derivatise molecules from our stock of over 25,000 molecules.
What we offer: